Douglas Dahl, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Abbott
    Date added:
    Date updated:
    01/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    C.R. Bard
    Date added:
    Date updated:
    01/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Pfizer
    Date added:
    Date updated:
    01/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Roche
    Date added:
    Date updated:
    01/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Novartis
    Date added:
    Date updated:
    01/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Bristol Myers Squibb
    Date added:
    Date updated:
    01/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Eli Lilly
    Date added:
    Date updated:
    01/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Merck
    Date added:
    Date updated:
    01/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    GlaxoSmithKline
    Date added:
    Date updated:
    01/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Abbvie
    Date added:
    Date updated:
    01/27/2022

Pages

Return to Webinar: Prostate Cancer Update (2020)